T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.18% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
FIGS
FIGS
$2.44B
| $37M | ﹤0.01% |
4,062,794
-13,419,461
| -77% | -$171M |
|
|
RUTH
977
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $36.8M | ﹤0.01% |
2,266,027
+48,258
| +2% | +$928K |
|
978
Fabrinet
FN
$20.4B
| $36.8M | ﹤0.01% |
453,655
+11,300
| +3% | +$1.02M |
|
979
Clean Harbors
CLH
$17B
| $36.7M | ﹤0.01% |
418,761
+100,533
| +32% | +$9.7M |
|
980
Alaska Air
ALK
$5.13B
| $36.7M | ﹤0.01% |
916,521
+199,558
| +28% | +$9.74M |
|
981
Box
BOX
$4.52B
| $36.7M | ﹤0.01% |
1,459,320
-21,153
| -1% | -$591K |
|
|
DAWN
982
DELISTED
Day One Biopharmaceuticals
DAWN
| $36.5M | ﹤0.01% |
2,041,344
+455,603
| +29% | +$4.7M |
|
|
ARIS
983
DELISTED
Aris Water Solutions
ARIS
| $36M | ﹤0.01% |
2,160,423
-378,231
| -15% | -$6.86M |
|
984
Diodes
DIOD
$4.77B
| $35.7M | ﹤0.01% |
553,364
+11,765
| +2% | +$858K |
|
|
PFHD
985
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
| $35.6M | ﹤0.01% |
1,774,945
-6,335
| -0.4% | -$139K |
|
986
Skyworks Solutions
SWKS
$10.5B
| $35.5M | ﹤0.01% |
383,427
-3,507,663
| -90% | -$379M |
|
987
JELD-WEN Holding
JELD
$167M
| $35.4M | ﹤0.01% |
2,424,170
-5,507
| -0.2% | -$100K |
|
|
WBA
988
DELISTED
Walgreens Boots Alliance
WBA
| $35.3M | ﹤0.01% |
930,738
-102,007
| -10% | -$4.39M |
|
989
Lincoln Electric
LECO
$15.6B
| $34.8M | ﹤0.01% |
282,370
+9,038
| +3% | +$1.19M |
|
990
Lyell Immunopharma
LYEL
$342M
| $34.7M | ﹤0.01% |
266,375
-8,321
| -3% | -$850K |
|
991
Advanced Energy
AEIS
$13.2B
| $34.7M | ﹤0.01% |
475,781
-13,492
| -3% | -$1.04M |
|
992
Franklin Resources
BEN
$17.2B
| $34.5M | ﹤0.01% |
1,481,599
-52,494
| -3% | -$1.34M |
|
|
LL
993
DELISTED
LL Flooring Holdings, Inc.
LL
| $34.5M | ﹤0.01% |
3,685,602
+3,062
| +0.1% | +$37.4K |
|
994
Church & Dwight Co
CHD
$24B
| $34.4M | ﹤0.01% |
371,710
-51,750
| -12% | -$4.89M |
|
995
Kraft Heinz
KHC
$30.3B
| $34.4M | ﹤0.01% |
902,750
-842,024
| -48% | -$33.7M |
|
996
Eagle Materials
EXP
$6.4B
| $34.2M | ﹤0.01% |
311,274
-15,219
| -5% | -$1.87M |
|
997
Metropolitan Bank Holding Corp
MCB
$1.17B
| $34.1M | ﹤0.01% |
491,621
-3,617
| -0.7% | -$300K |
|
998
Axalta
AXTA
$7.99B
| $34M | ﹤0.01% |
1,538,200
+1,362,617
| +776% | +$34.6M |
|
999
Albany International
AIN
$1.84B
| $33.7M | ﹤0.01% |
427,849
-57,141
| -12% | -$4.65M |
|
1000
Howard Hughes
HHH
$3.98B
| $33.6M | ﹤0.01% |
517,727
-137,262
| -21% | -$11.3M |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.